Jefferies analyst Jack Slevin maintained a Hold rating on Cross Country Healthcare today and set a price target of $8.65.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jack Slevin has given his Hold rating due to a combination of factors surrounding Cross Country Healthcare’s recent developments. The termination of the proposed acquisition by Aya has resulted in CCRN receiving a $20 million termination fee, which they plan to use for immediate share buybacks. This strategic move is supported by their strong net cash position, which stands at approximately $115 million after accounting for the breakup fee.
Despite the potential for a modest recovery in fundamentals now that the acquisition distraction is removed, the company’s current financial trajectory remains uncertain. The lack of fourth-quarter guidance following the deal termination adds to the near-term risk, prompting a cautious stance. Consequently, Slevin adjusted the price target to $8.65, reflecting a slightly lower valuation due to these uncertainties, while maintaining a Hold rating as they await more concrete signs of fundamental improvement.